omt-28
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 8, 2017 (NCT03078738)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- omt-28
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05972954 | Phase 2 | May 22, 2023 | Omeicos Therapeutics GmbH |
| NCT03906799 | Phase 2 | Mar 19, 2019 | Omeicos Therapeutics GmbH |
| NCT03078738 | Phase 1 | Feb 8, 2017 | Omeicos Therapeutics GmbH |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Omeicos Therapeutics GmbH | For profit | 3 | 3 | 2 | 2017 |
1 organizations
Page 1 / 1